Press release
The Secret of Life - Ancient Biotechnology Evolution
Image: https://timesfeatured.com/wp-content/uploads/2025/12/Zarkaish-Pic-744x1024.jpegDr. Zarkaish Ismail - whose identify means "Gold Feather" - is a biotechnology and dermatology entrepreneur and the Co-Founder-Chief Executive Officer of Kore Secrets Trademark , a revolutionary biotechnology lab and manufacturing firm primarily based in United States, who channels deep scientific biotechnology into concrete social function from a number of historical communities: increasing entry to high quality healthcare via the inclusion of ancient organic information, stem cells, exosomes, DNA & bio-minerals primarily based nano-peptide rejuvenate molecular processes.
Dr. Zarkaish motto - "Let's Hope, Let's Innovate, and Let's Develop."
Dr. Zarkaish's career blends clinical care, advanced training, and field-driven discovery. After earning her medical degree, she pursued executive studies in Nutrition and Physical Health at the University of Pittsburgh; Healthcare Management at Johns Hopkins University; Skin Care at Harvard Medical School; Innovating in Health Care at Harvard Business School; and "Biology - The Secret of Life" at MIT.
Image: https://timesfeatured.com/wp-content/uploads/2025/12/11.jpeg
Dr. Zarkaish's clinical focus on dermatology and biotechnology broadened into an enduring fascination with longevity, stem cells, exosomes, peptides, and DNA-level mechanisms of aging Fieldwork in places such as Chitral in northern Pakistan - where communities report exceptional longevity (an average lifespan approaching 120 years), pregnancies in the mid-sixties, and unusual patterns of vitality - sparked ethnobotanical and lifestyle investigations across Central Asia, the Middle East, Europe, and East Asia.
Guided by respectful local collaboration and ethical sourcing, she collected botanical samples and lifestyle data, searching for reproducible molecular signals - Nano peptides, exosome profiles, and other bioactive candidates - that might modulate inflammation, enhance repair, and support tissue resilience.
Image: https://timesfeatured.com/wp-content/uploads/2025/12/1.jpeg
Laboratory validation of these leads led Dr. Ismail to found Kore Secrets Trademark in the United States, a high-tech biotechnology lab dedicated to translating those discoveries into evidence-based formulations and therapies. Kore Secrets Trademark emphasizes rigorous preclinical testing, controlled clinical trials, transparent benefit-sharing with source communities, and inclusive biotechnology practices so that advancements uplift both individuals and societies.
Image: https://timesfeatured.com/wp-content/uploads/2025/12/222.jpeg
Dr. Zarkaish work is not about sensational promises but about rebuilding cellular regeneration and rejuvenation - using biotechnology-inspired nano-peptides and exosome-informed approaches - to improve skin health through regeneration, reduce age-related decline, and support healthier lifespans.
By synthesizing clinical insight, molecular science, and culturally informed fieldwork, she offers a compelling model for responsible innovation: harnessing knowledge from ancient Korean and Himalayan traditions and other remote cultures without exploitation, validating it with modern science, and deploying it in ways that expand opportunity and well-being for humankind.
Image: https://timesfeatured.com/wp-content/uploads/2025/12/2.jpeg
The author conducted an in-depth interview with Dr. Zarkaish Ismail about her work and vision in founding Kore Secrets, a biotechnology laboratory in the United States, and her goals for advancing human longevity, health, and beauty.
For more details & collaboration: click
https://www.linkedin.com/in/zarkaish/
Media Contact
Company Name: Kore Secrets Trademark
Contact Person: Caroline Smith
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-secret-of-life-ancient-biotechnology-evolution]
Country: United States
Website: https://koresecrets.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Secret of Life - Ancient Biotechnology Evolution here
News-ID: 4312098 • Views: …
More Releases from ABNewswire
Migraine Therapeutic Pipeline Witnesses Significant Expansion as 30+ Pharma Comp …
DelveInsight's, "Migraine Pipeline Insight 2026" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Migraine pipeline landscape. It covers the Migraine pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Migraine Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead in understanding the Migraine Treatment Landscape @ Migraine…
Obesity Clinical Trial Ecosystem Strengthens with 80+ Companies Driving Next-Gen …
DelveInsight's "Obesity Pipeline Insight 2026" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the obesity pipeline landscape. It covers the Obesity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Obesity pipeline products in this space.
Download DelveInsight's comprehensive Obesity Pipeline Report to explore emerging…
Chronic Kidney Disease Drug Development Pipeline Expands as 75+ Companies Focus …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2026" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Kidney Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Multiple System Atrophy Clinical Pipeline Intensifies with 20+ Industry Players …
DelveInsight's "Multiple System Atrophy Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Multiple System Atrophy pipeline landscape. It covers the Multiple System Atrophy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple System Atrophy Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…
